Insulin aspart, recombinant Subcutaneous and Verapamil Extended Release Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Verapamil Extended Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Verapamil Extended Release Tablets
- Insulin aspart, recombinant Subcutaneous-Verapamil Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Verapamil Hydrochloride PM
- Insulin aspart, recombinant Subcutaneous-Verapamil Immediate-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Verapamil Injection
- Insulin aspart, recombinant Subcutaneous-Verapamil Intravenous
- Verapamil Extended Release Capsules-Insulin degludec
- Verapamil Extended Release Capsules-Insulin Degludec (U-100) Prefilled Pens
- Verapamil Extended Release Capsules-Insulin Degludec (U-100) Vials
- Verapamil Extended Release Capsules-Insulin Degludec (U-200) Prefilled Pens
- Verapamil Extended Release Capsules-Insulin degludec and liraglutide
- Verapamil Extended Release Capsules-Insulin degludec and liraglutide Subcutaneous